High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

por Chow, S., Galvis, V., Pillai, M., Leach, R., Keene, E., Spencer-Shaw, A., Shablak, A., Shanks, J., Liptrot, T., Thistlethwaite, F., Hawkins, R. E.
Publicado 2016